Amgen Inc. is a biotechnology company that discovers, develops and makes biologic medicines. Its products include treatments for anaemia, complications of cancer chemotherapy, osteoporosis and inflammatory conditions, along with supportive therapies used in oncology and nephrology. Customers are mainly hospitals, clinics and physicians, with sales through distributors and partners in many countries. The company is based in Thousand Oaks, California, in the United States, and its medicines reach patients across international markets.
On this site Amgen Inc. appears as a stock on the London Exchange (UK), code 0R0T, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #149 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
91/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average21.7%
From 52-week high0.0%
MomentumStrong
87/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return22.8%
6-month return31.5%
12-month, skipping last month39.5%
Stability (higher is calmer)Strong
74/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)28.4%
Worst drawdown, 1 year (smaller is calmer)-16.7%
LiquidityFair
52/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.93M USD
Zero-volume days6.7%
IncomeFair
61/100
Dividend is typical for this exchange.
See the numbers →
Dividend yield2.2%
Years with dividends6
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 288.02 – 450.98Daily closes, split-adjusted
Signals
50-day average416.69
200-day average368.74
Golden/death cross (60d)None
New 52-week highYes
Bullish RSI divergenceNo
Average daily range (ATR)12.63
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
429.3
Bullish
EMA 10
430.8
Bullish
SMA 20
420.2
Bullish
EMA 20
422.8
Bullish
SMA 50
416.7
Bullish
EMA 50
411.5
Bullish
SMA 100
391.9
Bullish
EMA 100
395.6
Bullish
SMA 200
368.7
Bullish
EMA 200
371.9
Bullish
Oscillators (daily)
RSI (14)
67.02
Neutral
MACD (12, 26)
8.68
Bullish
Momentum (12)
11.40
Bullish
Stochastic %K (14)
95.62
Bearish
Williams %R (14)
-4.38
Bearish
CCI (20)
163.8
Bearish
Pivot points (classic, last session)
S3
425.1
S2
430.7
S1
439.7
Pivot
445.3
R1
454.3
R2
460.0
R3
468.9
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Dividends
Paid, last 12 months
9.94 USD
Yield on today's price
2.22%
Frequency
Quarterly
Next ex-dividend date
Not announced
Ex-dividend date
Amount per share
2.5200
2.5200
2.5200
2.3800
2.3800
2.3800
2.3800
2.2500
2.2500
2.2500
2.2500
2.1300
Ex-dividend dates and amounts from EODHD. Shown as declared, before tax.
Prices are end-of-day closes in USD. Educational only, not financial advice.
